# Precigen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/precigen

- Industry: Biotechnology
- Headquarters: Germantown, US
- Website: www.precigen.com
- Total disclosed funding: $362M
- Latest round: Series F (May 15, 2013)
- Investors on record: 2

## About

Precigen, Inc. is a US-based biopharmaceutical company focused on precision medicine aimed at developing innovative treatments for unmet medical needs, specializing in immuno-oncology, autoimmune disorders, and infectious diseases.Founded in 1998 in Germantown, US, Precigen, Inc. specializes in advanced biopharmaceutical technologies. The company has undergone strategic shifts to enhance its focus on precision medicine. It has raised USD 75.00 mn in its latest funding round, a Private Placement/Follow on, bringing its total funding to USD 75.00 mn. Precigen was part of Intrexon Corporation's portfolio until recently, which has influenced its operational strategies.Precigen, Inc. develops innovative biopharmaceuticals, including its core product, PAPZIMEOS (zopapogene imadenovec-drba), a subcutaneous injection targeting specific patient conditions. The company leverages advanced gene and cell therapies to deliver next-generation treatments primarily in North America, aimed at healthcare providers, hospitals, and specialty clinics.In the most recent year, Precigen reported a revenue of USD 3.93 mn with an EBITDA of USD -130.50 mn. The revenue is generated from direct sales of its products, including PAPZIMEOS, through agreements with healthcare providers.Precigen plans to utilize recent funding to establish exclusive channel collaborations, enhance its technology platforms, and expand its sales and marketing efforts. The company is focusing on launching new products and entering additional markets, particularly targeting regions with high demand for innovative therapies by the end of 2024.

## Funding rounds

- Series F, May 15, 2013, $86M — Third Security, Sandbox Industries
- Series F, Mar 1, 2013, $64M — Third Security, Sandbox Industries
- Series E, May 31, 2011, $100M — Third Security
- Series D, Nov 15, 2010, $38M — Third Security
- Series C, Jan 8, 2010, $25M — Third Security
- Series C, Jun 23, 2009, $10M — Third Security
- Series C, May 7, 2008, $25M — Third Security
- Series C, May 11, 2007, $13M — Third Security
- Series B, Mar 2, 2006, $1M — Third Security
- Series B, May 17, 2005, $0.5M — Third Security

## Investors

- Third Security (https://capitalatlas.ai/funds/third-security) — Series B, Series C, Series D, Series E, Series F
- Sandbox Industries (https://capitalatlas.ai/funds/sandbox-industries) — Series F